TABLE 1.
Baseline Anthropometric, Clinical, and Biochemical Data of Patients With Type 2 Diabetes According to Baseline CVD Status
| All Subjects(n = 158) | Subjects With No CV Events(n = 57) | Subjects With CV Events(n = 101) | P | |
|---|---|---|---|---|
| Age, years | 69 (45–90) | 66 (45–90) | 70 (47–86) | 0.24 |
| Female sex, % | 47.5 | 59.6 | 40.6 | 0.016 |
| Smoking habit, % | 19.6 | 15.8 | 21.8 | 0.24 |
| Diabetes duration, years | 14 (2–40) | 13 (2–25) | 15 (4–40) | 0.045 |
| BMI, kg/m2 | 30.7 (5.1) | 30.6 (5.0) | 30.8 (5.2) | 0.77 |
| SBP, mmHg | 137.4 (91–213) | 140 (98–213) | 135 (91–180) | 0.20 |
| DBP, mmHg | 80 (50–120) | 80 (60–120) | 80 (50–99) | 0.55 |
| Hemoglobin, g/dL | 12.4 (7.3–16.7) | 12.4 (9.3–15.9) | 12.4 (7.3–16.7) | 0.90 |
| A1C, % | 7.4 (5.0–11.6) | 7.2 (5.0–10.0) | 7.5 (5.6–11.6) | 0.052 |
| Albumin, g/dL | 4.2 (2.8–5.0) | 4.2 (2.9–4.9) | 4.1 (2.8–5.0) | 0.24 |
| CRP, mg/dL | 0.24 (0–14) | 0.20 (0–4.0) | 0.33 (0–14.0) | 0.12 |
| Total cholesterol, mg/dL | 168.5 (69–416) | 166 (100–416) | 169 (69–345) | 0.53 |
| LDL cholesterol, mg/dL | 93 (27–325) | 94 (30–325) | 92 (27–245) | 0.76 |
| HDL cholesterol, mg/dL | 45.0 (12.4) | 47.6 (11.3) | 43.5 (12.8) | 0.042 |
| Triglycerides, mg/dL | 142.5 (27–966) | 140 (27–551) | 147 (52–966) | 0.14 |
| eGFR, mL/min/1.73 m2 | 41.3 (4–106.3) | 57.3 (4.0–106.3) | 38.4 (4.0–106.2) | 0.14 |
| UPCR, g/g | 0.39 (0.01–9.7) | 0.25 (0.01–9.7) | 0.48 (0.01–7.0) | 0.50 |
| UACR, mg/g | 0.08 (0.001–65) | 0.04 (0.001–65) | 0.13 (0.02–70) | 0.16 |
| Oxidized LDL, units/L | 61.06 (17.9–123.4) | 61.06 (17.9–103.8) | 61.06 (22–123.4) | 0.23 |
| cIMT, mm | 0.86 (0.40–1.78) | 0.78 (0.40–1.78) | 0.90 (0.55–1.76) | <0.0001 |
Results for continuous variables are presented as mean (SD) or median (range). P values are from t test or Mann-Whitney U test for differences of variables and χ2 test for differences in frequencies among groups according to CVD status. Bold type indicates statistical significance.